Stellvertretend für drei Branchen: Anglogold (AU, Gold), Chiron (CHIR, Biotech), Microstrategy (MSTR, Software):
Anglogold:
Friday January 31, 1:31 am ET
AngloGold Ltd. - Johannesburg. AngloGold/Fiscal Year 2002: EPS $1.69 Versus $1.31 In 01
Year to December 31:
All figures in U.S. dollars
2002 2001
Net Profit 332.0 Mln 245.0 Mln
Operating Profit 650.0 Mln 517.0 Mln
Headline EPS 169.0 Cents 131.0 Cents
Gold Produced/Ounces 5.9 Mln 7.0 Mln
Dividend 142 Cents 87 Cents
Total Cash Costs ($/Oz) 161.0 178.0
(Ein fantastisches Ergebnis, wie ich meine. Vor allem unter dem Aspekt, dass der Goldpreis in 2002 noch deutlich tiefer stand als aktuell. Falls die Goldunze das jetzige Niveau hält oder sogar noch steigert, ist noch einiges zu erwarten. Die Würze liegt in der Dividende, die dem Ergebnis angepasst wird.)
Chiron:
Chiron fourth-quarter profit rises 49 percent
LOS ANGELES, Jan 29 (Reuters) - Biotechnology company Chiron Inc. (NasdaqNM:CHIR - News) on Wednesday said its quarterly net profit rose 49 percent on higher sales of products such as its inhaled antibiotic and test for detecting HIV in donated blood.
The Emeryville, California-based company said its fourth-quarter net income rose to $67 million, or 35 cents a share, from $45 million, or 23 cents a share, a year earlier. Revenue rose 12 percent to $356 million.
The company repeated its previous projection for earnings per share of $1.40 to $1.50 for 2003, compared with the current First Call estimate of $1.46.
(Der aktuelle Kurs liegt bei ca 37,50 USD. Damit ist die Bewertung für eine Growth-Company, die bereits deutliche Gewinne erwirtschaftet, recht günstig. Allerdings scheiden sich die Geister: Es gibt Stimmen, die Chiron nicht als Growth Company bezeichnen. Das sehe ich allerdings anders, da die Gesellschaft viele Produkte in der Pipe hat.)
Microstrategy:
MicroStrategy swings to profit, stock rises
Thursday January 30, 5:41 pm ET
MCLEAN, Va., Jan 30 (Reuters) - Business software maker MicroStrategy Inc.(Nasdaq:MSTRD - News) on Thursday said it swung to a fourth-quarter profit from the year-earlier loss, on higher key software sales and a 27 percent expense reduction.
The McLean, Virginia-based maker of software that scours business data for valuable trends, said its net income was $4.6 million, or 33 cents per diluted share. The result included restructuring, impairment and amortization charges of $2.9 million and a $2 million gain from the early, partial repayment of debt.
A year earlier, MicroStrategy had a fourth-quarter net loss of $24 million, or $2.61 per share.
Revenues fell to $42 million from $43.7 million last year, as a decline in services revenues more than offset a 9 percent increase in software license sales.
Looking ahead, the company forecast first-quarter revenue of $33 million to $37 million. It said its per-share results could be between a loss of 2 cents and a profit of 4 cents.
The company in March 2000 was forced to restate three years of profits as losses. Its stock plunged 62 percent in one day from its all-time high of $333.
MicroStrategy eventually paid $11 million to settle restatement-related charges with the U.S. Securities and Exchange Commission. It also handed over $10 million in stock to shareholders to settle a private lawsuit.
(MSTR ist sicherlich der spekulativste Hinweis. Sollte es der aber Gesellschaft gelingen, in einer wieder wachsenden Volkswirtschaft wieder auf Wachstumskurs zu gehen, so kann man von der Aktie noch einiges erwarten.)
Anglogold:
Friday January 31, 1:31 am ET
AngloGold Ltd. - Johannesburg. AngloGold/Fiscal Year 2002: EPS $1.69 Versus $1.31 In 01
Year to December 31:
All figures in U.S. dollars
2002 2001
Net Profit 332.0 Mln 245.0 Mln
Operating Profit 650.0 Mln 517.0 Mln
Headline EPS 169.0 Cents 131.0 Cents
Gold Produced/Ounces 5.9 Mln 7.0 Mln
Dividend 142 Cents 87 Cents
Total Cash Costs ($/Oz) 161.0 178.0
(Ein fantastisches Ergebnis, wie ich meine. Vor allem unter dem Aspekt, dass der Goldpreis in 2002 noch deutlich tiefer stand als aktuell. Falls die Goldunze das jetzige Niveau hält oder sogar noch steigert, ist noch einiges zu erwarten. Die Würze liegt in der Dividende, die dem Ergebnis angepasst wird.)
Chiron:
Chiron fourth-quarter profit rises 49 percent
LOS ANGELES, Jan 29 (Reuters) - Biotechnology company Chiron Inc. (NasdaqNM:CHIR - News) on Wednesday said its quarterly net profit rose 49 percent on higher sales of products such as its inhaled antibiotic and test for detecting HIV in donated blood.
The Emeryville, California-based company said its fourth-quarter net income rose to $67 million, or 35 cents a share, from $45 million, or 23 cents a share, a year earlier. Revenue rose 12 percent to $356 million.
The company repeated its previous projection for earnings per share of $1.40 to $1.50 for 2003, compared with the current First Call estimate of $1.46.
(Der aktuelle Kurs liegt bei ca 37,50 USD. Damit ist die Bewertung für eine Growth-Company, die bereits deutliche Gewinne erwirtschaftet, recht günstig. Allerdings scheiden sich die Geister: Es gibt Stimmen, die Chiron nicht als Growth Company bezeichnen. Das sehe ich allerdings anders, da die Gesellschaft viele Produkte in der Pipe hat.)
Microstrategy:
MicroStrategy swings to profit, stock rises
Thursday January 30, 5:41 pm ET
MCLEAN, Va., Jan 30 (Reuters) - Business software maker MicroStrategy Inc.(Nasdaq:MSTRD - News) on Thursday said it swung to a fourth-quarter profit from the year-earlier loss, on higher key software sales and a 27 percent expense reduction.
The McLean, Virginia-based maker of software that scours business data for valuable trends, said its net income was $4.6 million, or 33 cents per diluted share. The result included restructuring, impairment and amortization charges of $2.9 million and a $2 million gain from the early, partial repayment of debt.
A year earlier, MicroStrategy had a fourth-quarter net loss of $24 million, or $2.61 per share.
Revenues fell to $42 million from $43.7 million last year, as a decline in services revenues more than offset a 9 percent increase in software license sales.
Looking ahead, the company forecast first-quarter revenue of $33 million to $37 million. It said its per-share results could be between a loss of 2 cents and a profit of 4 cents.
The company in March 2000 was forced to restate three years of profits as losses. Its stock plunged 62 percent in one day from its all-time high of $333.
MicroStrategy eventually paid $11 million to settle restatement-related charges with the U.S. Securities and Exchange Commission. It also handed over $10 million in stock to shareholders to settle a private lawsuit.
(MSTR ist sicherlich der spekulativste Hinweis. Sollte es der aber Gesellschaft gelingen, in einer wieder wachsenden Volkswirtschaft wieder auf Wachstumskurs zu gehen, so kann man von der Aktie noch einiges erwarten.)
